Annita Tanini Sells 1,224 Shares of Keros Therapeutics (NASDAQ:KROS) StockMarket Beat·Aug 20 at 09:23 PMKROS-0.09%BLK-2.38%
Lorena Raquel Lerner Sells 3,568 Shares of Keros Therapeutics (NASDAQ:KROS) StockMarket Beat·Aug 20 at 09:22 PMKROS-0.09%
Keros Therapeutics director Charles W. Newton sells 551 common shares worth $5,675.3PUBT·Aug 20 at 08:10 PMKROS-0.09%
Keros Therapeutics director Jean Jacques Bieneaime acquires USD 10,270 in common sharesPUBT·Aug 19 at 08:10 PMKROS-0.09%
Keros Therapeutics controller, VP finance Annita Tanini files initial beneficial ownership statementPUBT·Aug 13 at 08:15 PMKROS-0.09%
Hold Rating Maintained as Pipeline Progress Offsets Long-Term Uncertainty; Price Target Reaffirmed at $16Tip Ranks·Aug 4 at 07:55 PMKROS-0.09%
Keros updates TGF-β pipeline strategy in new presentationTip Ranks·Aug 3 at 08:36 PMKROS-0.09%TAK+1.39%
Keros Therapeutics | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 0Earnings Watch·Aug 3 at 08:03 PMKROS-0.09%
Keros Q2 FY26 net loss narrows to $28.7 million; R&D expenses drop 48.74% to $22.3 millionPUBT·Aug 3 at 08:01 PMKROS-0.09%TAK+1.39%
Keros Therapeutics to receive $20 million Takeda milestone payment for elritercept Phase 3 dosingPUBT·Jul 30 at 08:09 PMKROS-0.09%TAK+1.39%
Keros Therapeutics names Annita Tanini interim CFO as Keith Regnante resignsPUBT·Jul 22 at 08:02 PMKROS-0.09%
Keros Therapeutics Director Jean Jacques Bienaime buys USD 10,610 in common sharesPUBT·Jul 17 at 08:10 PMKROS-0.09%
